Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.

Harder J, Müller MJ, Fuchs M, Gumpp V, Schmitt-Graeff A, Fischer R, Frank M, Opitz O, Hasskarl J.

World J Gastroenterol. 2013 Dec 28;19(48):9334-42. doi: 10.3748/wjg.v19.i48.9334.

2.

Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.

Mern DS, Hasskarl J, Burwinkel B.

Br J Cancer. 2010 Oct 12;103(8):1237-44. doi: 10.1038/sj.bjc.6605897. Epub 2010 Sep 14.

3.

Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells.

Manthey C, Mern DS, Gutmann A, Zielinski AJ, Herz C, Lassmann S, Hasskarl J.

BMC Cell Biol. 2010 Jan 14;11:2. doi: 10.1186/1471-2121-11-2.

4.

Severe Organizing Pneumonia after Two Cycles of Docetaxel as Fourth-Line Chemotherapy for Advanced Non-Small Cell Carcinoma of the Lung.

Hasskarl J, Schroettner P, von den Berg A, Rueckert A, Frydrychowicz A, Kayser G, Waller CF.

Case Rep Oncol. 2009 Feb 16;2(1):12-19.

5.

Complete caval thrombosis secondary to an implanted venous port--a case study.

Hasskarl J, Köberich S, Frydrychowicz A, Illerhaus G, Waller CF.

Dtsch Arztebl Int. 2008 Jan;105(1-2):18-21. doi: 10.3238/arztebl.2008.0018. Epub 2008 Jan 7.

6.

Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1.

Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Münger K.

Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9637-41.

Supplemental Content

Loading ...
Support Center